TABLE 1.
General characteristics of the study population
| Overall (n = 1432) | |
|---|---|
| Age, years, median (Q1–Q3) | 57 (43–69) |
| Gender | |
| Male, n (%) | 817 (56.9) |
| Female, n (%) | 618 (43.1) |
| Medication taken regularly a | |
| NSAIDs or paracetamol, n (%) | 31 (2.9) |
| Opioid, n (%) | 5 (0.5) |
| Benzodiazepines, n (%) | 96 (9.0) |
| Antidepressants, n (%) | 30 (2.8) |
| Anticonvulsant, n (%) | 20 (1.9) |
| Aetiology (pure) | |
| Biliary, n (%) | 564 (39.4) |
| Alcoholic, n (%) | 305 (21.3) |
| Hypertriglyceridaemic, n (%) | 83 (5.8) |
| Post‐ERCP, n (%) | 41 (2.9) |
| Idiopathic, n (%) | 300 (20.9) |
| Other, n (%) | 139 (9.7) |
| Length of hospital stay, median (Q1–Q3) | 9 (6–13) |
| Mortality, n (%) | 36 (2.5) |
| Severity of pancreatitis | |
| Mild, n (%) | 987 (68.9) |
| Moderate, n (%) | 368 (25.7) |
| Severe, n (%) | 77 (5.38) |
| Local complications, n (%) | 435 (30.5) |
| Fluid collection, n (%) | 373 (26.2) |
| Pseudocyst, n (%) | 126 (8.8) |
| Necrosis, n (%) | 132 (9.3) |
| Systemic complication, n (%) | 115 (8.1) |
| Respiratory failure, n (%) | 68 (4.8) |
| Heart failure, n (%) | 26 (1.8) |
| Renal failure, n (%) | 43 (3.0) |
a
Data on medication taken regularly were available in 1069 cases.